Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

GlaxoSmithKline (GSK) has been awarded a contract by the State of Texas under contract identification number HHSTX-6-0000408426, effective July 6, 2026. The contract authorizes GSK to provide pricing for childhood vaccines referencing the current Centers for Disease Control and Prevention (CDC) Federal Contract for Vaccine and Biologicals (CDC Federal Contract Number: 75D30126D20728). The procurement was executed under the authority of Texas Government Code Section 2155.144, which permits the acquisition of goods or services for the benefit of clients served by state agency programs, and falls under the purview of Texas Government Code Section 771.

The contracted goods encompass a range of vaccine and immunological products, including vaccines and antigens, toxoids, combination toxoids and vaccines, poultry vaccines, immunostimulating agents, and sterile diluents for PPR (porcine parvovirus) vaccine. These products are classified under UNSPSC codes 51201600, 51201700, 51201800, 51202100, and 41121523, as well as NIGP code 26980 (Serums, Toxoids, and Vaccines). Specific contract value, cumulative value, and performance period information were not disclosed in the award documentation provided.